Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Challenge: Developing novel diagnostic strategies

The award-winning suspected cancer (SCAN) pathway was developed in 2017 to accelerate cancer diagnosis in patients with non-specific but concerning symptoms of cancer. Initially deployed in Oxford, where patients undergo a full body low-dose Computed Tomography scan, blood, urine and stool tests resulting in 2-3 new cancer cases diagnosed each week, this innovate approach is now being rolled out nationally. Oxford Cancer infrastructure is enhancing the ability of this resource to allow early and peri-cancer biology studies across multiple disease sites and act as a test bed for integrating novel multi-parametric multi-cancer diagnostic platforms.